These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 15946131

  • 1. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H, Iwasaki Y, Nouso K, Kobayashi Y, Nakamura S, Matsumoto E, Toshikuni N, Kaneyoshi T, Ohsawa T, Takaguchi K, Fujio K, Senoh T, Ohnishi T, Sakaguchi K, Shiratori Y.
    J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
    [Abstract] [Full Text] [Related]

  • 2. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Jun; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 3. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 4. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M.
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [Abstract] [Full Text] [Related]

  • 5. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 6. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R.
    J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
    [Abstract] [Full Text] [Related]

  • 7. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M.
    Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
    [Abstract] [Full Text] [Related]

  • 8. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 9. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
    Cho EJ, Kwack MS, Jang ES, You SJ, Lee JH, Kim YJ, Yoon JH, Lee HS.
    Digestion; 2011 May; 84 Suppl 1():17-22. PubMed ID: 22156481
    [Abstract] [Full Text] [Related]

  • 10. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [Abstract] [Full Text] [Related]

  • 11. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H, Shiratori Y, Tateishi R, Fujishima T, Akamatsu M, Koike Y, Obi S, Hamamura K, Sato S, Teratani T, Shiina S, Omata M.
    Hepatogastroenterology; 2003 Jul; 50(54):2157-60. PubMed ID: 14696486
    [Abstract] [Full Text] [Related]

  • 12. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
    Tanaka K, Nagao Y, Ide T, Kumashiro R, Sata M.
    Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267
    [Abstract] [Full Text] [Related]

  • 13. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
    Omata M, Ashcavai M, Liew CT, Peters RL.
    Gastroenterology; 1979 Feb; 76(2):279-87. PubMed ID: 215488
    [Abstract] [Full Text] [Related]

  • 14. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S, Italian Association of the Study of the Liver Disease (AISF).
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [Abstract] [Full Text] [Related]

  • 15. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R.
    Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690
    [Abstract] [Full Text] [Related]

  • 16. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP).
    Am J Gastroenterol; 2002 Nov 15; 97(11):2886-95. PubMed ID: 12425564
    [Abstract] [Full Text] [Related]

  • 17. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec 15; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 18. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.
    Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327
    [Abstract] [Full Text] [Related]

  • 19. Tight association of hepatocellular carcinoma with HBV infection in North China.
    Gao JD, Shao YF, Xu Y, Ming LH, Wu ZY, Liu GT, Wang XH, Gao WH, Sun YT, Feng XL, Liang LM, Zhang YH, Sun ZT.
    Hepatobiliary Pancreat Dis Int; 2005 Feb 01; 4(1):46-9. PubMed ID: 15730918
    [Abstract] [Full Text] [Related]

  • 20. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD.
    Liver Int; 2005 Apr 01; 25(2):236-41. PubMed ID: 15780044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.